Fenofibrate lowers cardiac lipid accumulation and attenuates diabetic cardiomyopathy in db/db mice.

In the DCM model using db/db mice, the goal of this study was to assess the therapeutic potential of fenofibrate. Male mice aged 8 weeks were separated into four groups, two of which received db/db treatments with fenofibrate (n=4) and corn oil (vehicle, n=4).